We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$56.3B
AUM Growth
+$6.14B
Cap. Flow
+$1.76B
Cap. Flow %
3.13%
Top 10 Hldgs %
15.08%
Holding
4,631
New
103
Increased
2,522
Reduced
1,306
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 8.31%
2 Financials 6.96%
3 Consumer Discretionary 5.46%
4 Healthcare 4.97%
5 Industrials 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCTR icon
4276
Victory Capital Holdings
VCTR
$7.13B
$815 ﹤0.01%
53
MYOV
4277
DELISTED
Myovant Sciences Ltd.
MYOV
$801 ﹤0.01%
154
ACER
4278
DELISTED
Acer Therapeutics Inc
ACER
$791 ﹤0.01%
248
+235
+1,808% +$689
HOOK
4279
DELISTED
HOOKIPA Pharma
HOOK
$780 ﹤0.01%
10
+9
+900% +$664
MACK
4280
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$738 ﹤0.01%
164
-44
-21% -$220
MCF
4281
DELISTED
Contango Oil & Gas Co.
MCF
$703 ﹤0.01%
253
APLT
4282
DELISTED
Applied Therapeutics
APLT
$659 ﹤0.01%
+60
New +$566
DEO icon
4283
Diageo
DEO
$51.9B
$654 ﹤0.01%
4
+2
+100% +$335
HBP
4284
DELISTED
Huttig Building Products, Inc.
HBP
$592 ﹤0.01%
282
HNNA icon
4285
Hennessy Advisors
HNNA
$79.6M
$562 ﹤0.01%
52
CLDX icon
4286
Celldex Therapeutics
CLDX
$3.52B
$545 ﹤0.01%
256
-18
-7% -$42
SONM icon
4287
DNA X Inc
SONM
$5.22M
0
SIOX
4288
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$497 ﹤0.01%
77
ONCT
4289
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$485 ﹤0.01%
5
CTLP
4290
DELISTED
Cantaloupe
CTLP
$476 ﹤0.01%
65
-6,448
-99% -$46.3K
SAP icon
4291
SAP
SAP
$235B
$471 ﹤0.01%
4
+3
+300% +$371
AXLA
4292
DELISTED
Axcella Health Inc. Common Stock
AXLA
$458 ﹤0.01%
+3
New +$556
SNNA
4293
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$455 ﹤0.01%
2,275
BPL
4294
DELISTED
Buckeye Partners, L.P.
BPL
$452 ﹤0.01%
11
-37,110
-100% -$1.53M
PXLW icon
4295
Pixelworks
PXLW
$40.3M
$448 ﹤0.01%
10
HOS
4296
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$416 ﹤0.01%
548
FCEL icon
4297
FuelCell Energy
FCEL
$1.77B
$398 ﹤0.01%
41
ENT
4298
DELISTED
Global Eagle Entertainment Inc.
ENT
$377 ﹤0.01%
21
CVE icon
4299
Cenovus Energy
CVE
$55.5B
$366 ﹤0.01%
39
ZLAB icon
4300
Zai Lab
ZLAB
$2.85B
$356 ﹤0.01%
11

Similar funds

BNP Paribas Financial Markets's Q3 2019 Portfolio in Review

As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $235M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
  • BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
  • BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
  • BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
  • BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
  • BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
  • BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.